Cargando…
The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients
Several reports showed SARS-CoV-2 rapid antigen tests (RATs) performances among COVID-19 symptomatic subjects in outpatient settings during periods of highest incidence of infections and high rates of hospital admissions, but few data are present for asymptomatic patients. We investigated the role o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119292/ https://www.ncbi.nlm.nih.gov/pubmed/34007453 http://dx.doi.org/10.1016/j.nmni.2021.100899 |
_version_ | 1783691842556002304 |
---|---|
author | Caruana, G. Lebrun, L.-L. Aebischer, O. Opota, O. Urbano, L. de Rham, M. Marchetti, O. Greub, G. |
author_facet | Caruana, G. Lebrun, L.-L. Aebischer, O. Opota, O. Urbano, L. de Rham, M. Marchetti, O. Greub, G. |
author_sort | Caruana, G. |
collection | PubMed |
description | Several reports showed SARS-CoV-2 rapid antigen tests (RATs) performances among COVID-19 symptomatic subjects in outpatient settings during periods of highest incidence of infections and high rates of hospital admissions, but few data are present for asymptomatic patients. We investigated the role of RATs in an emergency department, as a novel screening tool before admission for COVID-19 asymptomatic patients. A total of 116 patients were screened on admission in a 250-bed community hospital in Morges, Switzerland. RAT detected 2/7 RT-PCR-positive patients and delivered two false-positive results. These data suggest the non-fiability of RATs screening in this clinical scenario. |
format | Online Article Text |
id | pubmed-8119292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-81192922021-05-14 The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients Caruana, G. Lebrun, L.-L. Aebischer, O. Opota, O. Urbano, L. de Rham, M. Marchetti, O. Greub, G. New Microbes New Infect New Technologies for Infectious and Tropical Diseases Several reports showed SARS-CoV-2 rapid antigen tests (RATs) performances among COVID-19 symptomatic subjects in outpatient settings during periods of highest incidence of infections and high rates of hospital admissions, but few data are present for asymptomatic patients. We investigated the role of RATs in an emergency department, as a novel screening tool before admission for COVID-19 asymptomatic patients. A total of 116 patients were screened on admission in a 250-bed community hospital in Morges, Switzerland. RAT detected 2/7 RT-PCR-positive patients and delivered two false-positive results. These data suggest the non-fiability of RATs screening in this clinical scenario. Elsevier 2021-05-14 /pmc/articles/PMC8119292/ /pubmed/34007453 http://dx.doi.org/10.1016/j.nmni.2021.100899 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | New Technologies for Infectious and Tropical Diseases Caruana, G. Lebrun, L.-L. Aebischer, O. Opota, O. Urbano, L. de Rham, M. Marchetti, O. Greub, G. The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients |
title | The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients |
title_full | The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients |
title_fullStr | The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients |
title_full_unstemmed | The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients |
title_short | The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients |
title_sort | dark side of sars-cov-2 rapid antigen testing: screening asymptomatic patients |
topic | New Technologies for Infectious and Tropical Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119292/ https://www.ncbi.nlm.nih.gov/pubmed/34007453 http://dx.doi.org/10.1016/j.nmni.2021.100899 |
work_keys_str_mv | AT caruanag thedarksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT lebrunll thedarksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT aebischero thedarksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT opotao thedarksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT urbanol thedarksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT derhamm thedarksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT marchettio thedarksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT greubg thedarksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT caruanag darksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT lebrunll darksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT aebischero darksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT opotao darksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT urbanol darksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT derhamm darksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT marchettio darksideofsarscov2rapidantigentestingscreeningasymptomaticpatients AT greubg darksideofsarscov2rapidantigentestingscreeningasymptomaticpatients |